Navigation Links
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Date:7/1/2009

rg>Johns Hopkins School of Medicine; co-winner, 1978 Albert Lasker Award; winner, 2003 National Medal of Science (United States)
  • Mary-Claire King, Ph.D., American Cancer Society Professor of Medicine and Genome Sciences, University of Washington, Seattle; member, National Academy of Sciences; member, American Academy of Arts and Sciences (United States)
  • Jean Marie Lehn, Ph.D., professor, College de France; winner, 1987 Nobel Laureate in Chemistry (France)
  • Craig Mello, Ph.D., professor, Molecular Medicine, University of Massachusetts Medical School and investigator, Howard Hughes Medical Institute; winner, 2006 Nobel Laureate in Physiology or Medicine; winner, 2006 Dr. Paul Janssen Award for Biomedical Research (United States)
  • Hartmut Michel, Ph.D., director, Department of Molecular Membrane Biology, University of Frankfurt; winner, 1988 Nobel Laureate in Chemistry (Germany)
  • Edward Scolnick, M.D., director, Psychiatry Initiative at the Broad Institute; former president, Merck Research Laboratories; member, National Academy of Sciences, the American Academy of Arts and Sciences and the Institute of Medicine (United States)
  • Sir Richard Sykes, Ph.D., chair, National Health Service, London; former rector Imperial College London; former chief executive officer, GlaxoWellcome; fellow of the Royal Society; honorary fellow of the Royal Society of Chemistry and fellow of the Academy of Medical Sciences (United Kingdom)

    • About Johnson & Johnson Pharmaceutical Services, L.L.C.

    Johnson & Johnson Pharmaceutical Services, L.L.C. is a part of the Johnson & Johnson Family of Companies. Caring for the world, one person at a time ... inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the
    '/>"/>

    SOURCE Johnson & Johnson
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5

    Related biology technology :

    1. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
    2. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
    3. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
    4. Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
    5. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
    6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
    7. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
    8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
    9. Video: Keppra XR(TM) Approved in the U.S.
    10. Video: Fortune 1000 Executives: New President Must Fix Education Gap
    11. Video: Moms Raise Red Flag About the Dangers of Widely Undiagnosed Bleeding Disorder

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/6/2009)...NTO, Nov. 6 /PRNewswire-FirstCall/ - Microbix Bios...t has re-filed the Form 52-109F1 Certification of ...ive Officer and James Long, the Chief Financial Of... 12, 2009 in connection with the annual audited fi..., 2008. ,, The Company initially filed the annu...
    (Date:11/6/2009)...ROOK, N.Y., Nov. 6 BioSp...pharmaceutical company developing first-in-class c...ancial results for the third quarter ended Septemb... in September of this year, the FDA,s Arthritis Ad...e of 12-0, the approval of XIAFLEX(TM) for the tre...
    (Date:11/6/2009)...RA, Ontario, Nov. 6 Heli...HXBPF) today announced that John Docherty, preside...rriman Curhan Ford,s 6th annual Investor Summit on... in New York City. Mr. Docherty will provide an o...nt programs L-DOS47 and Topical Interferon Alpha-2...
    (Date:11/6/2009)...CY, Mass., Nov. 6 Myriant Technolo...veloper and manufacturer of renewable bio-chemica...technology provider Uhde GmbH, one of the world,s ...announced an alliance for the engineering, procure...d Succinic Acid plants based on renewable feedstoc...
    Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3
    ...lar, Inc., an,Atlanta-based company dedicated to d...ix (ECM(TM)) biomaterial devices that harness the ...ular tissue, today announced,that Robert G. Mathen...ta,on the company,s next generation ECM Technology...erapeutics (TCT) 2008 conference in,Washington, D....
    ..., SAN DIEGO, Oct. 10 PURE Bioscience (Nasdaq:,PU...its fourth quarter and,year end results on or befo...tly host a conference call on Thursday, October 16...ll will consist of prepared,remarks from managemen...,web cast at http://www.purebio.com . Shareholder...
    ...maceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) annou...ings ("EGMs") held earlier today., The outcome of...assed,and Jennifer L. Good and Kenneth J. Zuerblis...ny until October 10, 2011. Following the EGMs, XTL...ood and Dr. William Kennedy., With the election o...
    Other Biology Technology:CorMatrix Cardiovascular to Present Data on Its Next Generation ECM Technology(TM) at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, D.C. 2PURE Bioscience to Announce Fourth Quarter and Fiscal 2008 Results 2
    (Date:11/4/2009)..., CARLSBAD, Calif., Oct. 23 GenV...e biosample management for genomic discovery, medi...d Wellis, Ph.D., GenVault,s President and CEO, wil...taking place on October 26th and 27th in La Jolla,...l provide an overview of the company together with...
    (Date:11/4/2009)...,, CHAPEL HILL Scientists at the University o... and the University of California, San Francisco h...e to predict new target diseases for existing drug...ethod that compares how similar the structures of ...ding partners -- known as ligands -- of disease ta...
    (Date:11/3/2009)... MADISON, WI, NOVEMBER 4, 2009 -- The world,s gre...among grape variety, human input, and something ca...vineyard site, soil, and climate. , Experts wi...e in a symposium on Wednesday, Nov. 4 in Pittsburg... be presented in two parts at the 2009 Annual Meet...
    Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Study points to new uses, unexpected side effects of already existing drugs 2Great wines come from great soils 2Everock Inc Completes Reverse Merger with Privately Held All Natural Food Producer Natures Peak 50545 1Everock Inc Completes Reverse Merger with Privately Held All Natural Food Producer Natures Peak 50545 2Everock Inc Completes Reverse Merger with Privately Held All Natural Food Producer Natures Peak 50545 3Biocept Inc Announces Two New Director Appointments 12871 1Biocept Inc Announces Two New Director Appointments 12871 2Tempe Based Marketing Agency Receives Prestigious National Healthcare Marketing Award Several Regional Awards 50541 1Tempe Based Marketing Agency Receives Prestigious National Healthcare Marketing Award Several Regional Awards 50541 2Tempe Based Marketing Agency Receives Prestigious National Healthcare Marketing Award Several Regional Awards 50541 3
    ...the world die of this type of meningitis, accordin...l meningitis, as the disease is called, can even s...cted in a matter of weeks in the late 1990s. With...the disease is 85-90 percent, with treatment some ...erious disability after recovery. , Only humans ar...
    ...ental disorder characterized by severely impaired ...t is thought that genetic make-up predisposes an i...ssociated with the development of autism. Although...d to be associated with susceptibility to autism, ... implicated in the disorder until researchers from...
    ...r pigs, especially in intensive production. Piglet...ons, restricting their growth rate; and often lead... routinely for many years to control these rapidly...mainly due to the increase in resistant strains of... using a lectin obtained from the red kidney bean ...
    Other Biology News:A healthier start to a pig's life 2
    Goat Anti-TNF-R2 (L-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
    H2A.X Phosphorylation Assay Kit (Flow Cytometry) from Upstate
    ...400 Spun Columns, 10. *SizeSep 400 Spun Columns: ... base pairs in length. - *Prepacked with Sep...er containing 0.15% Kathon CG/IcP Biocide. *Remov...mely useful in the construction of size-selected c...
    Propidium Iodide Solution [3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide] from CHEMICON
    Biology Products: